Abstract

Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations

Author(s): Okeke Claudia C, Allen Loyd V Jr

Issue: May/Jun 2010 - Pain Management

Page(s): 232-238

Download in electronic PDF format for $75

Abstract

Pharmacies should have standard operating procedures in place for each step involved in sterile compounding. These procedures include but are not limited to: storing; beyond-use dating; and maintaining the sterility, purity, and stability of compounded preparations. This article discusses the storage, beyond-use date, and the packing and transportation of finished compounded sterile preparations. The topics are discussed in a practical manner to provide practice clarification to the current standards set forth in the United States Pharmacopeia.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2010 Pg. 232-238	Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2008 Pg. 344-353	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 8; Stability and Beyond-Use Dating Author(s): Allen Loyd V Jr, Okeke Claudia C
Sep/Oct 2007 Pg. 404-410	Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2021 Pg. 491-496	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 92	PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 303-312	Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Author(s): Martin Matt
Sep/Oct 2008 Pg. 440-443	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 9: Immediate-Use Compounded Sterile Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
Mar/Apr 2008 Pg. 136-144	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2008 Pg. 524-528	Quality-Control Analytical Methods: Overview of Beyond-Use Dating for Compounded Sterile Preparations Author(s): Trissel Lawrence A
Mar/Apr 2005 Pg. 127-130	Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Newton David W
Jan/Feb 2008 Pg. 54-60	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 5: Verification of Accuracy, Sterility, and Sterilization of Compounded Preparations Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2008 Pg. 252-257	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 7: Microbial Contamination Risk Levels, 12-Hour Use, and Immediate Use Author(s): Allen Loyd V Jr, Okeke Claudia C
Nov/Dec 2011 Pg. 488-496	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3 Author(s): Allen Loyd V Jr
Jul/Aug 2007 Pg. 302-305	Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Okeke Claudia C
Mar/Apr 2005 Pg. 136-138	Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations Author(s): Kupiec Thomas C
May/Jun 2020 Pg. 180	PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2 Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 251-263	A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Author(s): Newton David W, Trissel Lawrence A
Mar/Apr 2004 Pg. 89-94	Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Author(s): Rahe Hank
Nov/Dec 2007 Pg. 492-499	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 4: Considerations in Selection and Use of Disinfectants and Antiseptics Author(s): Allen Loyd V Jr, Okeke Claudia C
May/Jun 2009 Pg. 234-238	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Author(s): Allen Loyd V Jr, Okeke Claudia C